lycium barbarum

Botanicalexperimental

Lycium barbarum is a shrub native to China, with present-day range across Asia and southeast Europe. It is one of two species of boxthorn in the family Solanaceae from which the goji berry or wolfberry is harvested, the other being Lycium chinense. — Wikipedia

Clinical trial activity

5 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2009 (NCT01142960)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    Unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • lycium barbarum

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04124276N/ANov 1, 2019Guangzhou Medical University
NCT04032795N/AAug 5, 2019Guangzhou Medical University
NCT02779985N/AApr 1, 2016Maastricht University
NCT02244996Phase 2Nov 1, 2014The Hong Kong Polytechnic University, The University of Hong Kong
NCT01142960N/ANov 1, 2009The Hong Kong Jockey Club Charities Trust, The Hong Kong Polytechnic University
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Guangzhou Medical UniversityAcademic/Hospital2212019
The Hong Kong Polytechnic UniversityAcademic/Hospital2222009
Maastricht UniversityAcademic/Hospital1112016
The Hong Kong Jockey Club Charities TrustAcademic/Hospital1012009
The University of Hong KongAcademic/Hospital1012014
5 organizations
Page 1 / 1